Wurst F M, Seidl S, Alt A, Metzger J
Psychiatrische Universitätsklinik Basel.
Psychiatr Prax. 2000 Nov;27(8):367-71.
In clinical as well as in forensic practice biological state markers of high sensitivity and specificity capable of monitoring alcohol consumption of those in treatment for alcohol dependence or poly-drug abusers are required. The known markers cannot be considered satisfactory in respect of these parameters. Furthermore, they do not cover the entire time axis for alcohol consumption. These traditional markers are often influenced besides by alcohol, by age, gender and various of substances and non-alcohol-associated diseases. Ethyl glucuronide (EtG) is a non volatile, water soluble, stable upon storage, direct metabolite of ethanol with a molecular weight of 222 g/mol that was determined by our group in more than 1200 samples of body fluids, tissues and hair from over 200 patients, almost 200 drivers and postmortem with different GC/MS and ESI-LC/MS-MS methods using deuterium-labelled EtG as internal standard. With its specific time frame of detection intermediate between short-term and long-term markers and a particularly high sensitivity and specificity, ethyl glucuronide is a promising marker of alcohol consumption in general that can be detected for an extended time period after the complete elimination of alcohol from the body (up tp 80 h) and a marker for relapse control enabling the therapist to intervene at an early stage of relapsing behaviour. The complementary use of EtG together with other upcoming markers of alcohol consumption like phosphatidyl ethanol should lead to an improvement in treatment outcome, quality of life and cost reduction.
在临床以及法医实践中,需要高灵敏度和特异性的生物状态标志物,以监测酒精依赖治疗患者或多药滥用者的酒精摄入量。就这些参数而言,已知的标志物并不令人满意。此外,它们并未涵盖酒精摄入的整个时间轴。这些传统标志物除了受酒精影响外,还常常受到年龄、性别、各种物质以及与酒精无关的疾病的影响。乙基葡萄糖醛酸苷(EtG)是一种非挥发性、水溶性、储存稳定的乙醇直接代谢产物,分子量为222 g/mol。我们团队使用氘标记的EtG作为内标,通过不同的气相色谱/质谱(GC/MS)和电喷雾电离液相色谱/串联质谱(ESI-LC/MS-MS)方法,在来自200多名患者、近200名司机和尸体的1200多个体液、组织和毛发样本中测定了EtG。乙基葡萄糖醛酸苷具有介于短期和长期标志物之间的特定检测时间框架,以及特别高的灵敏度和特异性,总体而言是一种很有前景的酒精摄入标志物,在酒精从体内完全消除后很长一段时间(长达80小时)都能检测到,并且是一种复发控制标志物,使治疗师能够在复发行为的早期阶段进行干预。将EtG与其他即将出现的酒精摄入标志物(如磷脂酰乙醇)联合使用,应能改善治疗效果、提高生活质量并降低成本。